The role of UBE2S in the chemoresistance of HCC is elucidated preliminarily, for the upregulation of UBE2S promotes the resistance of HCC cells to 5-FU and oxaliplatin through FOXM1-UBE2S-PTEN-p-AKT axis. Here, UBE2S is linked to hepatocellular carcinoma.